Navigation Links
Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook

ans on the importance of treating

I.V. pain and on the features and use of Zingo for their pediatric

patients. These initiatives will be complemented by Zingo co-promotion

and distribution partner Sagent Pharmaceuticals' representatives, who

will work primarily with hospital pharmacies.

-- Launched two initiatives aimed to improve peripheral venous access pain

management in children: RN VOICE (Registered Nurses for Venipuncture

Optimization through Increased Comfort and Education), a

multidisciplinary group of healthcare professionals led by nurses to

facilitate better management of venous access pain; and, an interactive Web site designed for

parents and healthcare providers seeking to better manage peripheral

venous access pain in children.

-- Proceeded with plans to file a supplemental New Drug Application with

the FDA in the first quarter of 2008 to expand the Zingo label to

include adults, based on successful pivotal Phase 3 trial in

approximately 700 adult patients.

-- Signed exclusive license agreement with Sigma-Tau SpA for the marketing

and distribution of Zingo in six European countries: Italy, France,

Germany, Netherlands, Belgium and Luxembourg. Sigma-Tau will oversee

all necessary regulatory filings, and will be responsible for all

marketing and sales of Zingo in their territory.

-- Granted an exclusive license to Medical Futures, Inc. for the marketing

and distribution of Zingo in Canada. Under the terms of the license,

Medical Futures will be responsible for all regulatory filings,

marketing, distribution and sales in Canada.

-- Conducted webcast and briefing in New York City with financial analysts

and major investors to present plans for

SOURCE Anesiva, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Anesiva Appoints Daniel Janney to Board of Directors
2. Anesiva Announces Fourth Quarter and Year End 2007 Financial Results Conference Call and February 2008 Conference Participation
3. Anesiva Announces Completion of Common Stock Offering
4. Anesiva Raises $45 Million in Common Stock Offering
5. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
6. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
7. Anesiva to Present at BioCenturys NewsMakers in the Biotech Industry Conference on September 6, 2007
8. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
9. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
10. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
11. Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital
Post Your Comments:
(Date:8/29/2014)... 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the ... results for the six months ended June 30, ... Canadian dollars and presented under International Financial Reporting ... , Announced top-line results related to ... for subjects enrolled in the Phase 2 iDEAL ...
(Date:8/29/2014)... Due to a misstatement posted by the ... Cell Technology Center, LLC ( ASCTC ) was reported as ... that might benefit ALS patients. Because of ASCTC's exclusive ... technologies and therapeutic applications, FRC listed ASCTC as one of ... who wish not to support research that requires the death ...
(Date:8/28/2014)... USA (PRWEB) August 28, 2014 SPIE ... of Physics and Optical Science and Director of the ... of North Carolina at Charlotte, and co-founder and Chairman ... to serve as the 2015 Vice President of SPIE, ... 2014 President Philip Stahl announced recent election results at ...
(Date:8/28/2014)... August 28, 2014 “This kit has an ... screen from 0 to 150 ppb,” said Mark Tess, PhD, ... significant benefit to plant owners and USDA-GIPSA inspection agencies that ... commodities. Testing can take place in a matter of minutes ... the plant test the feed and grain before accepting it, ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3Glenn Boreman, UNC Professor and Plasmonics Co-Founder, Elected to SPIE Presidential Chain 2
... ABBOTT PARK, Ill., Sept. 17 The board of directors of ... 40 cents per share. , , This marks the ... cash dividend is payable Nov. 15, 2009, to shareholders of record at the ... has increased its dividend payout for 37 consecutive years - including an 11 ...
... , BOULDER, Colo., Sept. 17 ... awarded two Phase I Small Business Innovation Research (SBIR) grants ... Infectious Diseases (NIAID) of The National Institutes of Health (NIH). ... toxicology and pharmacology studies of the company,s proprietary long-acting G-CSF ...
... CHENGDU, China, Sept. 17 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical, ... and supplier of,modernized traditional Chinese medicine (,TCM,) based in ... call to discuss its fiscal,2009 fourth quarter and full ... 2009. , Interested parties may ...
Cached Biology Technology:Bolder BioTechnology Receives $1.2 Million from NIH to Study Long-Acting G-CSF and GM-CSF Analogs in Treating Acute Radiation Syndrome 2Tianyin Pharmaceutical Co., Inc. to Host Fiscal 2009 Earnings Conference Call on Thursday, September 24, 2009 at 10:30 a.m. ET 2
(Date:8/29/2014)... how the repeated climatic shifts over the last ... genetic diversity, a team of researchers led by ... Carnaval developed a new biodiversity metric called "phylogeographic ... the genetic variation within species is restricted in ... of biology, and 14 other researchers from institutions ...
(Date:8/29/2014)... news release is available in German . ... chemical signals between organisms is considered the oldest form ... interactions between conspecifics, for example, the sexual attraction between ... social responses and to coordinate reproductive behavior in males ... the University of the Algarve in Faro, Portugal, and ...
(Date:8/29/2014)... them, fold them: modern materials that are light, flexible ... artificial skin or electronic paper. , Making such concepts ... a new way of working with copper nanowires and ... , Previous success in the field of ultra-lightweight "aerogel ... gold and silver nanowires. , By turning instead ...
Breaking Biology News(10 mins):CCNY team defines new biodiversity metric 2Ready for mating at the right time 2Ready for mating at the right time 3Copper shines as flexible conductor 2
... of Pittsburgh of UPMC have discovered a unique population of ... used to treat muscle injuries and diseases such as heart ... muscle tissue, scientists in Children,s Stem Cell Research Center - ... isolated and characterized stem cells taken from blood vessels (known ...
... MOUNTAIN VIEW, Calif., Aug. 13 LaserCard,Corporation (Nasdaq: ... ID credentials,used in biometric identification, today announced the ... Middle Eastern government. A new centralized high-volume ... the optical memory and the eye-readable data of,this ...
... N.Y., Aug. 15 bioMETRX, Inc. (OTC,Bulletin Board: BMRX), ... announced that it is has provided notice to,certain holders ... holders,must surrender said warrants to the company by August ... series B $0.10 warrants that it,has elected to pay ...
Cached Biology News:Pittsburgh scientists identify human source of stem cells with potential to repair muscle 2Pittsburgh scientists identify human source of stem cells with potential to repair muscle 3LaserCard Corporation Announces Expansion of Middle East Project 2LaserCard Corporation Announces Expansion of Middle East Project 3bioMETRX, Inc. Calls Series B Warrants 2
... consists of an anodized aluminum body in ... Compounds embedded in polymerized matrix. It is ... and Synergy Multi-Detection Readers. This multi-functional test ... reducing the need for tedious wet testing. ...
... Safe DNA Gel Stain combo offers these benefits: ... same products separately Offers ... Eliminates risks to yourself, the ... fragments from 100 bp to >30 kb. UltraPure Agarose ...
... economical ICS-90 uses continuous chemical suppression and ... you fast, accurate determinations of common anions ... to operate, quick to equilibrate, and fully ... ICS-90 helps you achieve maximum sample throughput ...
... DNA Gel Stain combo offers these benefits: ... products separately Offers a ... Eliminates risks to yourself, the environment ... from 100 bp to >30 kb. UltraPure Agarose is ...
Biology Products: